Who owns the CHIVAX trademark?

The CHIVAX trademark is owned by Virion Therapeutics, LLC.

What class is the CHIVAX trademark registered in?

The CHIVAX trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CHIVAX?

The USPTO serial number for CHIVAX is 97262974.

What is the registration number for CHIVAX?

CHIVAX is registered under USPTO registration number 0.

Sealvo

Home Search: CHIVAXCHIVAX #97262974

Back

Updated Sep 28, 2026·40 searches this week

View on USPTO TSDR Find similar marks

CHI

USPTO Trademark Record

PENDING

CHIVAX

SN 97262974·Reg 0·Filed Feb 11, 2022

Owner Virion Therapeutics, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CHIVAX (Serial No. 97262974), Registration No. 0, is a pending US trademark filed on Feb 11, 2022 by Virion Therapeutics, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for CHIVAX (SN 97262974) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CHIVAX (Reg. #0) is a pending US trademark that was filed in 2022 and is currently under USPTO examination. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 11, 2022

SERIAL

97262974

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateFeb 11, 2022

Serial Number97262974

Registration No.0

Registration DateDec 31, 1969

Status DateJul 11, 2026

Published for OppositionMay 02, 2023

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 26, 2018

First use in commerce: Sep 26, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

38 events

STATEMENT OF USE PROCESSING COMPLETE

Jul 11, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jun 26, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jun 26, 2026

USE AMENDMENT FILED

SOU EXTENSION 5 GRANTED

Dec 10, 2025

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 10, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 26, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Nov 25, 2025

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 06, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jun 06, 2025

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jun 06, 2025

SOU EXTENSION 4 GRANTED

SOU EXTENSION 3 GRANTED

Feb 13, 2025

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 13, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 10, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Nov 22, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Nov 22, 2024

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 26, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 25, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Apr 25, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Apr 25, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 27, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 25, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 25, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 25, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 27, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 02, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 02, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 12, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 29, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 04, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 03, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 03, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 06, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 06, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 06, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 28, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 16, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 15, 2022

NEW APPLICATION ENTERED

Other Marks by Virion Therapeutics, LLC

Additional USPTO filings from the same owner.

VVI

V VIRION THERAPEUTICS

88300800

Virion Therapeutics, LLC

REGISTERED

88162136

Virion Therapeutics, LLC

REGISTERED

VRO

VRON

97262984

Virion Therapeutics, LLC

PENDING

VIR

VIRION THERAPEUTICS

97262970

Virion Therapeutics, LLC

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CHI

CHIVAX

88512579

Virion Therapeutics, LLC

ABANDONED

CHI

CHIVAX-GD

88512576

Virion Therapeutics, LLC

ABANDONED

Other Marks by Kevin M. Bovard

Additional USPTO filings handled by the same attorney of record.

VVI

V VIRION THERAPEUTICS

88300800

REGISTERED

KKA

K KALIBRATE

97670253

REGISTERED

KAL

KALIBRATE

97670245

REGISTERED

CAS

CASCADE CPA

99406626

REGISTERED

CHIVAX

Run a conflict check

Other Marks by Virion Therapeutics, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Kevin M. Bovard

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company